A microbial sensor for discovering structural probes of protein misfolding and aggregation
บทความในวารสาร
ผู้เขียน/บรรณาธิการ
กลุ่มสาขาการวิจัยเชิงกลยุทธ์
ไม่พบข้อมูลที่เกี่ยวข้อง
รายละเอียดสำหรับงานพิมพ์
รายชื่อผู้แต่ง: Waraho-Zhmayev D., Gkogka L., Yu T.-Y., Delisa M.P.
ผู้เผยแพร่: Taylor and Francis Group
ปีที่เผยแพร่ (ค.ศ.): 2013
วารสาร: Prion (1933-6896)
Volume number: 7
Issue number: 2
หน้าแรก: 151
หน้าสุดท้าย: 156
จำนวนหน้า: 6
นอก: 1933-6896
eISSN: 1933-690X
ภาษา: English-Great Britain (EN-GB)
ดูในเว็บของวิทยาศาสตร์ | ดูบนเว็บไซต์ของสำนักพิมพ์ | บทความในเว็บของวิทยาศาสตร์
บทคัดย่อ
In all cell types, protein homeostasis, or 'proteostasis,' is maintained by sophisticated quality control networks that regulate protein synthesis, folding, trafficking, aggregation, disaggregation, and degradation. In one notable example, Escherichia coli employ a proteostasis system that determines whether substrates of the twin-arginine translocation (Tat) pathway are correctly folded and thus suitable for transport across the tightly sealed cytoplasmic membrane. Herein, we review growing evidence that the Tat translocase itself discriminates folded proteins from those that are misfolded and/or aggregated, preferentially exporting only the former. Genetic suppressors that inactivate this mechanism have recently been isolated and provide direct evidence for the participation of the Tat translocase in structural proofreading of its protein substrates. We also discuss how this discriminatory 'folding sensor' has been exploited for the discovery of structural probes (e.g., sequence mutations, pharmacologic chaperones and intracellular antibodies) that modulate the folding and solubility of virtually any protein-of-interest, including those associated with aggregation diseases (e.g., a-synuclein and amyloid-฿ protein). Taken together, these studies highlight the utility of engineered bacteria for rapidly and inexpensively uncovering potent anti-aggregation factors. ฉ 2013 Landes Bioscience. ฉ 2013 Landes Bioscience.
คำสำคัญ
Amyloid-ß protein, Antibody therapies, Chemical chaperones, Directed evolution, Folding quality control, High-throughput screening, Protein misfolding disorders, Protein secretion, α-synuclein